Abstract P4-15-02: TILs Variations, Proliferative Response and PEPI Scores in Patients with Luminal Breast Cancer Receiving Neoadjuvant Letrozole-Palbociclib or Chemotherapy: an Extended Analysis of the NEOPAL Trial
CANCER RESEARCH(2019)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要